Dr. Richard Lee on why it’s “a wonderful time” for BPH treatment

“The take-home message is that for the appropriate patient, each of [these] technologies works well,” says Richard K. Lee, MD, MBA.

In this interview, Richard K. Lee, MD, MBA, discusses the recent paper European Urology Focus paper, New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review, for which he served senior author. Lee is an Associate Professor of Urology and Healthcare Policy & Research at Weill Cornell Medicine Department of Urology in New York City.

Related Content:

UTvBenign Prostatic Hyperplasia
Aquablation therapy improves bladder function in patients with BPH
Dr. Kramer on the efficacy of dutasteride in treating LUTS
Dr. Sorensen discusses the potential of ultrasound stone treatment